Cargando…
Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study
PURPOSE: To compare the effectiveness and safety of a drug in daily practice with the outcomes of a target non‐inferiority trial by rigorously mimickingin an observational study the trial's design features. METHODS: This cohort study was conducted using the British Clinical Practice Research Da...
Autores principales: | Althunian, Turki A., de Boer, Anthonius, Groenwold, Rolf H. H., Rengerink, Katrien O., Souverein, Patrick C., Klungel, Olaf H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687233/ https://www.ncbi.nlm.nih.gov/pubmed/32537897 http://dx.doi.org/10.1002/pds.5065 |
Ejemplares similares
-
Defining the noninferiority margin and analysing noninferiority: An overview
por: Althunian, Turki A., et al.
Publicado: (2017) -
Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review
por: Althunian, Turki A., et al.
Publicado: (2017) -
Noninferiority trials
por: Snapinn, Steven M
Publicado: (2000) -
Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021) -
Understanding noninferiority trials
por: Hahn, Seokyung
Publicado: (2012)